EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Radiofrequency Ablation on Uncovered Metal Stent Patency in Malignant Biliary Obstruction from Pancreatic Cancer

Lillian Wang, Shuji Mitsuhashi, Ryan J Law, Daniel M Simadibrata, Ross Dierkhising, Aishwarya Yamparala, Aliana Bofill-Garcia, Andrew C Storm, Eric J. Vargas, John A. Martin, Barham K Abu Dayyeh, Vinay Chandrasekhara

Endoscopy International Open · 26.10.2026

DOI: 10.1055/a-2989-1743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 26.10.2026. Verfasst von Lillian Wang und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TaeWoong Medical USA, National Institute of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims: Pancreatic ductal adenocarcinoma (PDAC) with malignant biliary obstruction is frequently unresectable and carries a median survival of less than one year. Uncovered self-expandable metal stents (UCSEMS) are standard for biliary decompression but are limited by tumor ingrowth. Temperature-controlled endobiliary radiofrequency ablation (TC-RFA) has been proposed to prolong stent patency. We evaluated the efficacy and safety of TC-RFA followed by UCSEMS compared with UCSEMS alone for PDAC-related biliary stricture. Patients and methods: In this single-center study, PDAC patients were prospectively treated with TC-RFA plus UCSEMS and compared with a retrospective cohort treated with UCSEMS alone. The primary outcome was time to recurrent biliary obstruction (TRBO) within six months. Secondary outcomes included technical and clinical success, adverse events (AEs), surgical resection, and mortality. Results: Among 176 patients, 129 received UCSEMS alone and 47 received TC-RFA plus UCSEMS. Technical success was higher with UCSEMS alone (100% vs. 95.7%; p = 0.02), while clinical success was similar between groups (94.4% vs. 95.7%; p = 0.72). Six-month cumulative incidence of recurrent biliary obstruction (RBO) was significantly higher with TC-RFA (56.5% vs. 24.0%; p

Förderung

  • TaeWoong Medical USA
  • National Institute of Health

Zitieren

APA

Wang, L., Mitsuhashi, S., Law, R. J., Simadibrata, D. M., Dierkhising, R., Yamparala, A., Bofill-Garcia, A., Storm, A. C., Vargas, E. J., Martin, J. A., Dayyeh, B. K. A., & Chandrasekhara, V. (2026). Impact of Radiofrequency Ablation on Uncovered Metal Stent Patency in Malignant Biliary Obstruction from Pancreatic Cancer. Endoscopy International Open. https://doi.org/10.1055/a-2989-1743

Vancouver

Wang L, Mitsuhashi S, Law RJ, Simadibrata DM, Dierkhising R, Yamparala A, et al. Impact of Radiofrequency Ablation on Uncovered Metal Stent Patency in Malignant Biliary Obstruction from Pancreatic Cancer. Endoscopy International Open. 2026. doi:10.1055/a-2989-1743

BibTeX
@article{Wang2026,
  author = {Wang, Lillian and Mitsuhashi, Shuji and Law, Ryan J and Simadibrata, Daniel M and Dierkhising, Ross and Yamparala, Aishwarya and Bofill-Garcia, Aliana and Storm, Andrew C and Vargas, Eric J. and Martin, John A. and Dayyeh, Barham K Abu and Chandrasekhara, Vinay},
  title = {Impact of Radiofrequency Ablation on Uncovered Metal Stent Patency in Malignant Biliary Obstruction from Pancreatic Cancer},
  journal = {Endoscopy International Open},
  year = {2026},
  doi = {10.1055/a-2989-1743}
}
Kostenlos starten →